Stock DYN DYNE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Dyne Therapeutics, Inc.

Equities

DYN

US26818M1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
26 USD +0.19% Intraday chart for Dyne Therapeutics, Inc. -0.31% +95.49%
May. 02 Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DYN Stock
  4. Revisions Dyne Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW